5,598 results on '"AbbVie"'
Search Results
152. Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (CREDO2)
153. Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)
154. Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury (iNSPIRE)
155. Evaluating the Chain of Addiction Care (CAC) (HepC:CAC)
156. Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
157. Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
158. Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2)
159. Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
160. Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia
161. Spanish Registry of Systemic Treatments in Psoriasis (Biobadaderm)
162. Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
163. Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring
164. Multi-center Study to Transplant Hepatitis-C Infected Kidneys (MYTHIC)
165. Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
166. Study of Oral Treatments for Hepatitis C (PRIORITIZE)
167. Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (DOPPLER)
168. Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA) (OKINADA)
169. German Spondyloarthritis Inception Cohort (GESPIC)
170. Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
171. Myeloma-Developing Regimens Using Genomics (MyDRUG) (MyDRUG)
172. Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis (PSOBIOTEQ)
173. Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
174. Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy
175. Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
176. Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
177. PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression
178. The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ? (CCP)
179. Venetoclax and Irinotecan in Relapsed/Refractory SCLC
180. Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response (HEPCASUS)
181. Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO
182. Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C
183. Stricture Definition and Treatment (STRIDENT) Drug Therapy Study (STRIDENT)
184. A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
185. Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer (VelGemRad)
186. A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
187. Use of Pancreatic Enzymes in Short Bowel Syndrome (SBS)
188. Skin Tape Harvesting for Transcriptomics Analysis
189. Malaria: Relative Bioavailability and Food Effect of DSM265
190. Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
191. A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
192. Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 (EXTEND)
193. Targeted Ultrasound in Rheumatoid Arthritis (TURA)
194. Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
195. Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab (SUSTAIN)
196. New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)
197. The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies (SpACE)
198. Pilot HCV Direct Acting Antiviral Therapy and Metabolism (3D)
199. Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B
200. MAP Study: Methotrexate and Adalimumab in Psoriasis (MAP)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.